Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs

Methods to evaluate renal function in elderly patients: a systematic literature review

(2010) G. Van Pottelbergh et al.   AGE AND AGEING

Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

(2010)   AMERICAN HEART JOURNAL

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

(2010) Joachim Stangier et al.   CLINICAL PHARMACOKINETICS

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

(2009) Alan S. Go et al.   CIRCULATION

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relation of Atrial Fibrillation to Glomerular Filtration Rate

(2008) Yasuyuki Iguchi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate

(2008) Joachim Stangier   CLINICAL PHARMACOKINETICS

Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease

(2008) H. Reinecke et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY